The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary

Journal of Heart and Lung Transplantation

Volumn 32, Issue 2, 2013, Pages 157-187

  Feldman, David ^b   Pamboukian, Salpy V ^b   Teuteberg, Jeffrey J ^b   Birks, Emma ^b   Lietz, Katherine ^b   Moore, Stephanie A ^b   Morgan, Jeffrey A ^b   Arabia, Francisco ^b   Bauman, Mary E ^b   Buchholz, Hoger W ^b   Eng, Mario ^b   Dickstein, Marc L ^b   El Banayosy, Aly ^b   Elliot, Tonya ^b   Goldstein, Daniel J ^b   Grady, Kathleen L ^b   Jones, Kylie ^b   Hryniewicz, Katarzyna ^b   John, Ranjit ^b   Kaan, Annemarie ^b   Kusne, Shimon ^b   Loebe, Matthias ^b   Massicotte, M Patricia ^b   Moazami, Nader ^b   Mohacsi, Paul ^b   Mooney, Martha ^b   Nelson, Thomas ^b   Pagani, Francis ^b   Perry, William ^b   Potapov, Evgenij V ^b   Eduardo Rame, J ^b   Russell, Stuart D ^b   Sorensen, Erik N ^b   Sun, Benjamin ^b   Strueber, Martin ^b   Mangi, Abeel A ^b   Petty, Michael G ^b   Rogers, Joseph ^b   Rowe, Amanda W ^a   more..

^a International Society for Heart and Lung Transplantation   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DOBUTAMINE; GLYCERYL TRINITRATE; HYDRALAZINE; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; VASOPRESSIN;

ACUTE HEART INFARCTION; ALCOHOL ABUSE; ANTIBIOTIC PROPHYLAXIS; AORTA STENOSIS; AORTA VALVE DISEASE; AORTA VALVE REGURGITATION; ARTICLE; ASSISTED CIRCULATION; BACTERIAL ENDOCARDITIS; BLOOD CLOTTING DISORDER; CLINICAL CLASSIFICATION; CLINICAL EVALUATION; COMORBIDITY; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; EXPECTATION; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM ARRHYTHMIA; HEART FAILURE; HEART INDEX; HEART SEPTUM DEFECT; HEART TRANSPLANTATION; HEMATOLOGIC DISEASE; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFECTION PREVENTION; INFECTION RISK; INSURANCE; INTRACARDIAC THROMBOSIS; LUNG TRANSPLANTATION; MECHANICAL CIRCULATORY SUPPORT; MEDICAL DOCUMENTATION; MITRAL VALVE STENOSIS; MULTIPLE ORGAN FAILURE; NEW YORK HEART ASSOCIATION CLASS; NUTRITIONAL ASSESSMENT; OBESITY; PALLIATIVE THERAPY; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK MANAGEMENT; SOCIAL NETWORK; SUBSTANCE ABUSE; SYSTOLIC HEART FAILURE; TRICUSPID VALVE REGURGITATION;

ASSISTED CIRCULATION; ENDOCARDITIS; HEART FAILURE; HEART VALVE DISEASES; HEART-LUNG TRANSPLANTATION; HUMANS; MYOCARDIAL ISCHEMIA; PATIENT EDUCATION AS TOPIC; PATIENT SELECTION; QUALITY OF LIFE; RISK ASSESSMENT; SOCIETIES, MEDICAL;

EID: 84872848201     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.09.013     Document Type: Article

References (350)

1. J.K. Kirklin, D.C. Naftel, and R.L. Kormos Third INTERMACS Annual Report: the evolution of destination therapy in the United States J Heart Lung Transplant 30 2011 115 123
2. S.J. Park, C.A. Milano, and A.J. Tatooles Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy Circ Heart Fail 5 2012 241 248
3. M.S. Slaughter, J.G. Rogers, and C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
4. J.K. Kirklin, D.C. Naftel, and R.L. Kormos Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants J Heart Lung Transplant 29 2010 1 10
5. G.C. Stewart, and L.W. Stevenson Keeping left ventricular assist device acceleration on track Circulation 123 2011 1559 1568
6. J.J. Teuteberg, G. Stewart, and M. Jessup Strategies for LVAD therapy in INTERMACS: intent rate versus event rate [abstract] J Heart Lung Transplant 29 2010 S26 S27
7. L.W. Stevenson, F.D. Pagani, and J.B. Young INTERMACS profiles of advanced heart failure: the current picture J Heart Lung Transplant 28 2009 535 541
8. W.C. Levy, D. Mozaffarian, and D.T. Linker The Seattle Heart Failure Model: prediction of survival in heart failure Circulation 113 2006 1424 1433
9. A. Goda, P. Williams, D. Mancini, and L.H. Lund Selecting patients for heart transplantation: comparison of the Heart Failure Survival Score (HFSS) and the Seattle heart failure model (SHFM) J Heart Lung Transplant 30 2011 1236 1243
10. W.C. Levy, D. Mozaffarian, D.T. Linker, D.J. Farrar, and L.W. Miller Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant 28 2009 231 236
11. A.P. Kalogeropoulos, V.V. Georgiopoulou, and G. Giamouzis Utility of the Seattle Heart Failure Model in patients with advanced heart failure J Am Coll Cardiol 53 2009 334 342
12. E.Z. Gorodeski, E.C. Chu, C.H. Chow, W.C. Levy, E. Hsich, and R.C. Starling Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee Circ Heart Fail 3 2010 706 714
13. S.V. Pamboukian, J.A. Tallaj, and R.N. Brown Comparison of observed survival with assist device versus predicted survival without device using the Seattle heart failure model ASAIO J 58 2012 93 97
14. K.D. Aaronson, J.S. Schwartz, T.M. Chen, K.L. Wong, J.E. Goin, and D.M. Mancini Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation Circulation 95 1997 2660 2667
15. M.N. Parikh, L.H. Lund, A. Goda, and D. Mancini Usefulness of peak exercise oxygen consumption and the heart failure survival score to predict survival in patients>65 years of age with heart failure Am J Cardiol 103 2009 998 1002
16. A. Goda, L.H. Lund, and D.M. Mancini Comparison across races of peak oxygen consumption and heart failure survival score for selection for cardiac transplantation Am J Cardiol 105 2010 1439 1444
17. P. Green, L.H. Lund, and D. Mancini Comparison of peak exercise oxygen consumption and the Heart Failure Survival Score for predicting prognosis in women versus men Am J Cardiol 99 2007 399 403
18. L.H. Lund, K.D. Aaronson, and D.M. Mancini Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure Am J Cardiol 95 2005 734 741
19. D.M. Mancini, H. Eisen, W. Kussmaul, R. Mull, L.H. Edmunds Jr, and J.R. Wilson Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure Circulation 83 1991 778 786
20. M.R. Mehra, J. Kobashigawa, and R. Starling Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates - 2006 J Heart Lung Transplant 25 2006 1024 1042
21. L.W. Stevenson, L.W. Miller, and P. Desvigne-Nickens Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure) Circulation 110 2004 975 981
22. R.E. Hershberger, D. Nauman, T.L. Walker, D. Dutton, and D. Burgess Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure J Card Fail 9 2003 180 187
23. M.J. Krell, E.M. Kline, and E.R. Bates Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure Am Heart J 112 1986 787 791
24. V. Rao, M.C. Oz, M.A. Flannery, K.A. Catanese, M. Argenziano, and Y. Naka Revised screening scale to predict survival after insertion of a left ventricular assist device J Thorac Cardiovasc Surg 125 2003 855 862
25. K. Lietz, J.W. Long, and A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection Circulation 116 2007 497 505
26. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
27. J.M. Schaffer, J.G. Allen, and E.S. Weiss Evaluation of risk indices in continuous-flow left ventricular assist device patients Ann Thorac Surg 88 2009 1889 1896
28. J. Teuteberg, G. Ewald, and R. Adamson Application of the destination therapy risk score to HeartMate II clinical trial data [abstract] [manuscript in press, JACC] J Heart Lung Transplant 30 2011 S31
29. A.J. Boyle, D.D. Ascheim, and M.J. Russo Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification J Heart Lung Transplant 30 2011 402 407
30. J. Cowger, K. Sundareswaran, and J. Rogers The HeartMate II risk score: Predicting survival in candidates for left ventricular assist device support [abstract] J Heart Lung Transplant 30 2011 S31
31. F.D. Pagani, L.W. Miller, and S.D. Russell Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
32. M. Strueber, G. O'Driscoll, P. Jansz, A. Khaghani, W.C. Levy, and G.M. Wieselthaler Multicenter evaluation of an intrapericardial left ventricular assist system J Am Coll Cardiol 57 2011 1375 1382
33. P. Johnsson, L. Algotsson, E. Ryding, E. Stahl, and K. Messeter Cardiopulmonary perfusion and cerebral blood flow in bilateral carotid artery disease Ann Thorac Surg 51 1991 579 584
34. M. Selim Angioplasty and stenting of asymptomatic carotid stenosis before cardiac surgery: more study is needed Arch Neurol 65 2008 1672 1674
35. H.L. Lazar, and J.O. Menzoian Coronary artery bypass grafting in patients with cerebrovascular disease Ann Thorac Surg 66 1998 968 974
36. E. Mikus, A. Stepanenko, and T. Krabatsch Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients Eur J Cardiothorac Surg 40 2011 971 977
37. N. Uriel, D.B. Sims, and U.P. Jorde Fixed pulmonary hypertension and mechanical support: an unclear opportunity J Heart Lung Transplant 30 2011 600
38. E. Mikus, A. Stepanenko, and T. Krabatsch Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making Eur J Cardiothorac Surg 39 2011 310 316
39. T.S. Kato, P.C. Schulze, and J. Yang Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device J Heart Lung Transplant 31 2012 1 8
40. Y. Wadia, W. Etheridge, F. Smart, R.P. Wood, and O.H. Frazier Pathophysiology of hepatic dysfunction and intrahepatic cholestasis in heart failure and after left ventricular assist device support J Heart Lung Transplant 24 2005 361 370
41. J.H. Levy, and A.M. Winkler Heparin-induced thrombocytopenia and cardiac surgery Curr Opin Anaesthesiol 23 2010 74 79
42. M.C. Morel-Kopp, M. Aboud, C.W. Tan, C. Kulathilake, and C. Ward Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies Thromb Res 125 2010 e234 e239
43. T.E. Warkentin, A. Greinacher, and A. Koster Heparin-induced thrombocytopenia in patients with ventricular assist devices: are new prevention strategies required? Ann Thorac Surg 87 2009 1633 1640
44. M.J. Zucker, I. Sabnani, D.A. Baran, S. Balasubramanian, and M. Camacho Cardiac transplantation and/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia J Heart Lung Transplant 29 2010 53 60
45. J. Butler, R. Howser, P.M. Portner, and R.N. Pierson 3rd Diabetes and outcomes after left ventricular assist device placement J Card Fail 11 2005 510 515
46. V.K. Topkara, N.C. Dang, and T.P. Martens Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation J Heart Lung Transplant 24 2005 2048 2053
47. N. Uriel, Y. Naka, and P.C. Colombo Improved diabetic control in advanced heart failure patients treated with left ventricular assist devices Eur J Heart Fail 13 2011 195 199
48. A. Kolesar, F. Sabol, J. Luczy, and M. Bajmoczi Use of left ventricle assist device in a pregnant woman with acute aortic and coronary dissections Interact Cardiovasc Thorac Surg 11 2010 194 195
49. S. LaRue, A. Shanks, I.W. Wang, G. Ewald, D. Anderson, and S. Joseph Left ventricular assist device in pregnancy Obstet Gynecol 118 2011 426 428
50. D. Oles, R. Berryessa, K. Campbell, and M.A. Bhatti Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report Perfusion 16 2001 159 164
51. D.B. Sims, J. Vink, and N. Uriel A successful pregnancy during mechanical circulatory device support J Heart Lung Transplant 30 2011 1065 1067
52. W.L. Holman, R.L. Kormos, and D.C. Naftel Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study J Heart Lung Transplant 28 2009 44 50
53. R.M. Adamson, M. Stahovich, and S. Chillcott Clinical strategies and outcomes in advanced heart failure patients older than 70 years of age receiving the HeartMate II left ventricular assist device: a community hospital experience J Am Coll Cardiol 57 2011 2487 2495
54. S. Cupples, M.A. Dew, and K.L. Grady Report of the Psychosocial Outcomes Workgroup of the Nursing and Social Sciences Council of the International Society for Heart and Lung Transplantation: present status of research on psychosocial outcomes in cardiothoracic transplantation: review and recommendations for the field J Heart Lung Transplant 25 2006 716 725
55. A.K. Eshelman, S. Mason, H. Nemeh, and C. Williams LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant Heart Fail Rev 14 2009 21 28
56. J.L. Levenson, and M.E. Olbrisch Psychosocial evaluation of organ transplant candidates. A comparative survey of process, criteria, and outcomes in heart, liver, and kidney transplantation Psychosomatics 34 1993 314 323
57. M.E. Olbrisch, S.M. Benedict, K. Ashe, and J.L. Levenson Psychological assessment and care of organ transplant patients J Consult Clin Psychol 70 2002 771 783
58. M.E. Olbrisch, and J.L. Levenson Psychosocial assessment of organ transplant candidates. Current status of methodological and philosophical issues Psychosomatics 36 1995 236 243
59. S. De Geest, I. Abraham, and P. Moons Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients J Heart Lung Transplant 17 1998 854 863
60. S. De Geest, F. Dobbels, S. Martin, K. Willems, and J. Vanhaecke Clinical risk associated with appointment noncompliance in heart transplant recipients Prog Transplant 10 2000 162 168
61. S. De Geest, F. Dobbels, C. Fluri, W. Paris, and T. Troosters Adherence to the therapeutic regimen in heart, lung, and heart-lung transplant recipients J Cardiovasc Nurs 20 2005 S88 S98
62. M.A. Dew, L.H. Roth, M.E. Thompson, R.L. Kormos, and B.P. Griffith Medical compliance and its predictors in the first year after heart transplantation J Heart Lung Transplant 15 1996 631 645
63. H. Nagele, P. Kalmar, W. Rodiger, and H.M. Stubbe Smoking after heart transplantation: an underestimated hazard? Eur J Cardiothorac Surg 12 1997 70 74
64. M.A. Dew, A.F. DiMartini, and J. Steel Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs Liver Transpl 14 2008 159 172
65. A. Kaan, Q.R. Young, S. Cockell, and M. Mackay Emotional experiences of caregivers of patients with a ventricular assist device Prog Transplant 20 2010 142 147
66. L. Marcuccilli, and J.M. Casida From insiders' perspectives: adjusting to caregiving for patients with left ventricular assist devices Prog Transplant 21 2011 137 143
67. B. Bunzel, K. Laederach-Hofmann, G.M. Wieselthaler, W. Roethy, and G. Drees Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: evaluation of patients and partners Transplant Proc 37 2005 1365 1368
68. B. Bunzel, K. Laederach-Hofmann, G. Wieselthaler, W. Roethy, and E. Wolner Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses J Heart Lung Transplant 26 2007 384 389
69. A.L. Raymond, A.G. Kfoury, and C.J. Bishop Obesity and left ventricular assist device driveline exit site infection ASAIO J 56 2010 57 60
70. F. Zahr, E. Genovese, and M. Mathier Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes Ann Thorac Surg 92 2011 1420 1426
71. R.J. Brewer, D.E. Lanfear, and C.B. Sai-Sudhakar Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantation J Heart Lung Transplant 31 2012 167 172
72. P. Dhesi, S.A. Simsir, D. Daneshvar, A. Rafique, A. Phan, and E.R. Schwarz Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure Ann Transplant 16 2011 5 13
73. K. Thompson, P. Dhesi, D. Nguyen, L. Czer, J. Moriguchi, and E. Schwarz Evaluation of the HeartMate II left ventricular assist device in obese heart failure patients: effects on weight loss Ann Transplant 16 2011 63 67
74. C.R. Butler, and B.I. Jugdutt Mechanical circulatory support for elderly heart failure patients Heart Fail Rev 17 2012 663 669
75. A.G. Rizzieri, J.L. Verheijde, M.Y. Rady, and J.L. McGregor Ethical challenges with the left ventricular assist device as a destination therapy Philos Ethics Humanit Med 3 2008 20
76. S.A. Hunt, W.T. Abraham, and M.H. Chin Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in collaboration with the International Society for Heart and Lung Transplantation J Am Coll Cardiol 53 2009 e1 e90
77. S. Brush, D. Budge, and R. Alharethi End-of-life decision making and implementation in recipients of a destination left ventricular assist device J Heart Lung Transplant 29 2010 1337 1341
78. S.E. Sandner, D. Zimpfer, and P. Zrunek Renal function and outcome after continuous flow left ventricular assist device implantation Ann Thorac Surg 87 2009 1072 1078
79. J. Butler, C. Geisberg, and R. Howser Relationship between renal function and left ventricular assist device use Ann Thorac Surg 81 2006 1745 1751
80. V.K. Topkara, N.C. Dang, and F. Barili Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device J Heart Lung Transplant 25 2006 404 408
81. C. Ootaki, M. Yamashita, and Y. Ootaki Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system J Thorac Cardiovasc Surg 136 2008 150 158
82. S.E. Sandner, D. Zimpfer, and P. Zrunek Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices J Heart Lung Transplant 27 2008 469 473
83. B. Radovancevic, B. Vrtovec, K.E. de, R. Radovancevic, I.D. Gregoric, and O.H. Frazier End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices J Heart Lung Transplant 26 2007 815 818
84. G.V. Letsou, T.J. Myers, and I.D. Gregoric Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months Ann Thorac Surg 76 2003 1167 1170
85. S.D. Russell, J.G. Rogers, and C.A. Milano Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device Circulation 120 2009 2352 2357
86. L.W. Miller, F.D. Pagani, and S.D. Russell Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
87. M.S. Slaughter, F.D. Pagani, and J.G. Rogers Clinical management of continuous-flow left ventricular assist devices in advanced heart failure J Heart Lung Transplant 29 2010 S1 39
88. M. Singh, M. Shullo, and R.L. Kormos Impact of renal function before mechanical circulatory support on posttransplant renal outcomes Ann Thorac Surg 91 2011 1348 1354
89. K. Holdy, W. Dembitsky, and L.L. Eaton Nutrition assessment and management of left ventricular assist device patients J Heart Lung Transplant 24 2005 1690 1696
90. M. Liszkowski, J. Teuteberg, and S. Myers INTERMACS profiles of nutrition and organ function in relation to outcomes [abstract] J Heart Lung Transplant 29 2010 S27
91. J. Nunez, G. Minana, and V. Bodi Low lymphocyte count and cardiovascular diseases Curr Med Chem 18 2011 3226 3233
92. O. Vardeny, J.J. Moran, N.K. Sweitzer, M.R. Johnson, and M.S. Hayney Decreased T-cell responses to influenza vaccination in patients with heart failure Pharmacotherapy 30 2010 10 16
93. M.G. Betjes, A.W. Langerak, A. van der Spek, E.A. de Wit, and N.H. Litjens Premature aging of circulating T cells in patients with end-stage renal disease Kidney Int 80 2011 208 217
94. A. Stofkova Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity Endocr Regul 43 2009 157 168
95. M.N. Acharya, R. Som, and S. Tsui What is the optimum antibiotic prophylaxis in patients undergoing implantation of a left ventricular assist device? Interact Cardiovasc Thorac Surg 14 2012 209 214
96. W.L. Holman, J.L. Skinner, K.B. Waites, R.L. Benza, D.C. McGiffin, and J.K. Kirklin Infection during circulatory support with ventricular assist devices Ann Thorac Surg 68 1999 711 716
97. S. Saito, G. Matsumiya, and T. Sakaguchi Long-term medical control of inflow cuff infection in a patient with a left ventricular assist system J Artif Organs 12 2009 58 60
98. J.M. Gelow, A.S. Desai, C.P. Hochberg, J.N. Glickman, M.M. Givertz, and J.C. Fang Clinical predictors of hepatic fibrosis in chronic advanced heart failure Circ Heart Fail 3 2010 59 64
99. J.C. Matthews, F.D. Pagani, J.W. Haft, T.M. Koelling, D.C. Naftel, and K.D. Aaronson Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality Circulation 121 2010 214 220
100. P.M. Concha, and K.V. Mertz [Perioperative risk among patients with cirrhosis] Rev Med Chil 138 2010 1165 1171
101. A. Modi, H.A. Vohra, and C.W. Barlow Do patients with liver cirrhosis undergoing cardiac surgery have acceptable outcomes? Interact Cardiovasc Thorac Surg 11 2010 630 634
102. O.H. Frazier, E.A. Rose, and M.C. Oz Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation J Thorac Cardiovasc Surg 122 2001 1186 1195
103. M.A. Khan, and S.F. Hussain Pre-operative pulmonary evaluation J Ayub Med Coll Abbottabad 17 2005 82 86
104. D.J. Wright, K.M. Khan, E.M. Gossage, and S. Saltissi Assessment of a low-intensity cardiac rehabilitation programme using the six-minute walk test Clin Rehabil 15 2001 119 124
105. G.W. Smetana Preoperative pulmonary evaluation N Engl J Med 340 1999 937 944
106. G.W. Smetana, V.A. Lawrence, and J.E. Cornell Preoperative pulmonary risk stratification for noncardiothoracic surgery: systematic review for the American College of Physicians Ann Intern Med 144 2006 581 595
107. L.W. Miller, and K. Lietz Candidate selection for long-term left ventricular assist device therapy for refractory heart failure J Heart Lung Transplant 25 2006 756 764
108. M.R. Miller, R. Crapo, and J. Hankinson General considerations for lung function testing Eur Respir J 26 2005 153 161
109. R. Pellegrino, G. Viegi, and V. Brusasco Interpretative strategies for lung function tests Eur Respir J 26 2005 948 968
110. M.Y. Rady, and T. Ryan Perioperative predictors of extubation failure and the effect on clinical outcome after cardiac surgery Crit Care Med 27 1999 340 347
111. L.E. Samuels, M.S. Kaufman, R.J. Morris, R. Promisloff, and S.K. Brockman Coronary artery bypass grafting in patients with COPD Chest 113 1998 878 882
112. J.B. Dimick, S.L. Chen, P.A. Taheri, W.G. Henderson, S.F. Khuri, and D.A. Campbell Jr. Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program J Am Coll Surg 199 2004 531 537
113. S.R. Bapoje, J.F. Whitaker, T. Schulz, E.S. Chu, and R.K. Albert Preoperative evaluation of the patient with pulmonary disease Chest 132 2007 1637 1645
114. A.M. Arozullah, J. Daley, W.G. Henderson, and S.F. Khuri Multifactorial risk index for predicting postoperative respiratory failure in men after major noncardiac surgery. The National Veterans Administration Surgical Quality Improvement Program Ann Surg 232 2000 242 253
115. J. Canet, L. Gallart, and C. Gomar Prediction of postoperative pulmonary complications in a population-based surgical cohort Anesthesiology 113 2010 1338 1350
116. K. Kroenke, V.A. Lawrence, J.F. Theroux, M.R. Tuley, and S. Hilsenbeck Postoperative complications after thoracic and major abdominal surgery in patients with and without obstructive lung disease Chest 104 1993 1445 1451
117. B.H. Culver How should the lower limit of the normal range be defined? Respir Care 57 2012 136 145
118. D.S. Feldman, T.S. Elton, B. Sun, M.M. Martin, and M.T. Ziolo Mechanisms of disease: detrimental adrenergic signaling in acute decompensated heart failure Nat Clin Pract Cardiovasc Med 5 2008 208 218
119. F.D. Pagani, W. Lynch, and F. Swaniker Extracorporeal life support to left ventricular assist device bridge to heart transplant: A strategy to optimize survival and resource utilization Circulation 100 1999 II206 II210
120. J.G. Copeland, R.G. Smith, and F.A. Arabia Cardiac replacement with a total artificial heart as a bridge to transplantation N Engl J Med 351 2004 859 867
121. T.A. Aziz, G. Singh, and E. Popjes Initial experience with CentriMag extracorporal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock J Heart Lung Transplant 29 2010 66 71
122. J. Bagai, D. Webb, and E. Kasasbeh Efficacy and safety of percutaneous life support during high-risk percutaneous coronary intervention, refractory cardiogenic shock and in-laboratory cardiopulmonary arrest J Invasive Cardiol 23 2011 141 147
123. J.C. Cleveland Jr, D.C. Naftel, and T.B. Reece Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database J Heart Lung Transplant 30 2011 862 869
124. T. Krabatsch, M. Schweiger, and A. Stepanenko Mechanical circulatory support-results, developments and trends J Cardiovasc Transl Res 4 2011 332 339
125. H. Thiele, P. Sick, and E. Boudriot Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock Eur Heart J 26 2005 1276 1283
126. A.E. Engstrom, R. Cocchieri, and A.H. Driessen The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience Crit Care Med 39 2011 2072 2079
127. M.S. Koeckert, U.P. Jorde, Y. Naka, J.W. Moses, H. Takayama, and L.P. Impella 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support J Card Surg 26 2011 666 668
128. B. Meyns, J. Dens, P. Sergeant, P. Herijgers, W. Daenen, and W. Flameng Initial experiences with the Impella device in patients with cardiogenic shock - Impella support for cardiogenic shock Thorac Cardiovasc Surg 51 2003 312 317
129. M.P. Siegenthaler, K. Brehm, and T. Strecker The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience J Thorac Cardiovasc Surg 127 2004 812 822
130. D. Feldman, D.M. Menachemi, W.T. Abraham, and R.K. Wexler Management strategies for stage-D patients with acute heart failure Clin Cardiol 31 2008 297 301
131. D.J. Farrar Ventricular interactions during mechanical circulatory support Semin Thorac Cardiovasc Surg 6 1994 163 168
132. D.J. Farrar, P.G. Compton, J.J. Hershon, J.D. Fonger, and J.D. Hill Right heart interaction with the mechanically assisted left heart World J Surg 9 1985 89 102
133. N.C. Dang, V.K. Topkara, and M. Mercando Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure J Heart Lung Transplant 25 2006 1 6
134. M.N. Kavarana, M.S. Pessin-Minsley, and J. Urtecho Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem Ann Thorac Surg 73 2002 745 750
135. Y. Ochiai, P.M. McCarthy, and N.G. Smedira Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients Circulation 106 2002 I198 I202
136. J.R. Fitzpatrick 3rd, J.R. Frederick, and W. Hiesinger Early planned institution of biventricular mechanical circulatory support results in improved outcomes compared with delayed conversion of a left ventricular assist device to a biventricular assist device J Thorac Cardiovasc Surg 137 2009 971 977
137. H. Tsukui, J.J. Teuteberg, and S. Murali Biventricular assist device utilization for patients with morbid congestive heart failure: a justifiable strategy Circulation 112 2005 I65 I72
138. M. Kukucka, A. Stepanenko, and E. Potapov Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices J Heart Lung Transplant 30 2011 64 69
139. J.C. Matthews, T.M. Koelling, F.D. Pagani, and K.D. Aaronson The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172
140. K. Furukawa, T. Motomura, and Y. Nose Right ventricular failure after left ventricular assist device implantation: the need for an implantable right ventricular assist device Artif Organs 29 2005 369 377
141. J.R. Fitzpatrick 3rd, J.R. Frederick, and V.M. Hsu Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support J Heart Lung Transplant 27 2008 1286 1292
142. R.L. Kormos, J.J. Teuteberg, and F.D. Pagani Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes J Thorac Cardiovasc Surg 139 2010 1316 1324
143. S. Chumnanvej, M.J. Wood, T.E. MacGillivray, and M.F. Melo Perioperative echocardiographic examination for ventricular assist device implantation Anesth Analg 105 2007 583 601
144. G. Osculati, G. Malfatto, R. Chianca, and G.B. Perego Left-to-right systolic ventricular interaction in patients undergoing biventricular stimulation for dilated cardiomyopathy J Appl Physiol 109 2010 418 423
145. J. Mau, S. Menzie, Y. Huang, M. Ward, and S. Hunyor Chronic septal infarction confers right ventricular protection during mechanical left ventricular unloading J Thorac Cardiovasc Surg 138 2009 172 178
146. A.M. Smith, C.M. Elliot, D.G. Kiely, and K.S. Channer The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension QJM 99 2006 127 133
147. Y. Ootaki, K. Kamohara, and M. Akiyama Phasic coronary blood flow pattern during a continuous flow left ventricular assist support Eur J Cardiothorac Surg 28 2005 711 716
148. E. Tuzun, K. Eya, and H.K. Chee Myocardial hemodynamics, physiology, and perfusion with an axial flow left ventricular assist device in the calf ASAIO J 50 2004 47 53
149. P. Voitl, M. Vollkron, H. Bergmeister, G. Wieselthaler, and H. Schima Coronary hemodynamics and myocardial oxygen consumption during support with rotary blood pumps Artif Organs 33 2009 77 80
150. G.V. Letsou, S. Sdringola, and I.D. Gregoric Myocardial perfusion as assessed by positron emission tomography during long-term mechanical circulatory support Congest Heart Fail 12 2006 69 74
151. S. Xydas, R.S. Rosen, and S. Pinney Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure J Heart Lung Transplant 24 2005 1976 1979
152. M.D. Forrester, T.J. Myers, I.D. Gregoric, and O.H. Frazier Saphenous vein graft flow during left ventricular assistance with an axial-flow pump Tex Heart Inst J 33 2006 222 224
153. S.P. Sommer, A. Gorski, and I. Aleksic Heartmate II implantation with right coronary bypass grafting in ischemic cardiomyopathy with fixed pulmonary hypertension: treatment strategy to protect right ventricular function J Card Surg 25 2010 116 119
154. E.V. Potapov, R. Sodian, M. Loebe, T. Drews, S. Dreysse, and R. Hetzer Revascularization of the occluded right coronary artery during left ventricular assist device implantation J Heart Lung Transplant 20 2001 918 922
155. R.A. Schroeder, G.L. Wood, J.S. Plotkin, and P.C. Kuo Intraoperative use of inhaled PGI(2) for acute pulmonary hypertension and right ventricular failure Anesth Analg 91 2000 291 295
156. K. Fattouch, F. Sbraga, and R. Sampognaro Treatment of pulmonary hypertension in patients undergoing cardiac surgery with cardiopulmonary bypass: a randomized, prospective, double-blind study J Cardiovasc Med (Hagerstown) 7 2006 119 123
157. R.R. Riker, Y. Shehabi, and P.M. Bokesch Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial JAM 301 2009 489 499
158. St A.C. Andre, and A. DelRossi Hemodynamic management of patients in the first 24 hours after cardiac surgery Crit Care Med 33 2005 2082 2093
159. A. El-Banayosy, R. Korfer, and L. Arusoglu Device and patient management in a bridge-to-transplant setting Ann Thorac Surg 71 2001 S98 102
160. A.J. Boyle, S.D. Russell, and J.J. Teuteberg Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation J Heart Lung Transplant 28 2009 881 887
161. R. John, F. Kamdar, and K. Liao Low thromboembolic risk for patients with the Heartmate II left ventricular assist device J Thorac Cardiovasc Surg 136 2008 1318 1323
162. M. Morshuis, A. El-Banayosy, and L. Arusoglu European experience of DuraHeart magnetically levitated centrifugal left ventricular assist system Eur J Cardiothorac Surg 35 2009 1020 1027
163. M.S. Slaughter, Y. Naka, and R. John Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy J Heart Lung Transplant 29 2010 616 624
164. R. Hetzer, T. Krabatsch, A. Stepanenko, E. Hennig, and E.V. Potapov Long-term biventricular support with the heartware implantable continuous flow pump J Heart Lung Transplant 29 2010 822 824
165. L.E. Samuels, J. Kohout, and E. Casanova-Ghosh Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices Ann Thorac Surg 85 2008 1651 1655
166. S. Schenk, L. Arusoglu, and M. Morshuis Triple bridge-to-transplant in a case of giant cell myocarditis complicated by human leukocyte antigen sensitization and heparin-induced thrombocytopenia type II Ann Thorac Surg 81 2006 1107 1109
167. S. Schenk, A. El-Banayosy, and W. Prohaska Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support J Thorac Cardiovasc Surg 131 2006 1373 1381
168. B. Brismar, G. Hedenstierna, H. Lundquist, A. Strandberg, L. Svensson, and L. Tokics Pulmonary densities during anesthesia with muscular relaxation - a proposal of atelectasis Anesthesiology 62 1985 422 428
169. A.F. van Belle, G.J. Wesseling, O.C. Penn, and E.F. Wouters Postoperative pulmonary function abnormalities after coronary artery bypass surgery Respir Med 86 1992 195 199
170. M.R. Pinsky Cardiovascular issues in respiratory care Chest 128 2005 592S 597S
171. J.K. Raikhelkar Mechanical ventilation for cardiac support Crit Care Clin 23 2007 291 298 xi
172. R.J. Tedford, A.R. Hemnes, and S.D. Russell PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support Circ Heart Fail 1 2008 213 219
173. D. Matamis, S. Pampori, and A. Papathanasiou Inhaled NO and sildenafil combination in cardiac surgery patients with out-of-proportion pulmonary hypertension: acute effects on postoperative gas exchange and hemodynamics Circ Heart Fail 5 2012 47 53
174. M. Hatano, K. Kinugawa, and T. Shiga Less frequent opening of the aortic valve and a continuous flow pump are risk factors for postoperative onset of aortic insufficiency in patients with a left ventricular assist device Circ J 75 2011 1147 1155
175. K. Toda, T. Fujita, K. Domae, Y. Shimahara, J. Kobayashi, and T. Nakatani Late aortic insufficiency related to poor prognosis during left ventricular assist device support Ann Thorac Surg 92 2011 929 934
176. J.O. Mudd, J.D. Cuda, M. Halushka, K.A. Soderlund, J.V. Conte, and S.D. Russell Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device J Heart Lung Transplant 27 2008 1269 1274
177. International Society for Heart and Lung Transplantation. A 2010 working formulation for the standardization of definitions of infections in patients using ventricular assist devices (VADs). http://www.ishlt.org/contentdocument/ VAD.pdf. 2010.
178. R.J. Gordon, B. Quagliarello, and F.D. Lowy Ventricular assist device-related infections Lancet Infect Dis 6 2006 426 437
179. P.M. Kimball, M. Flattery, F. McDougan, and V. Kasirajan Cellular immunity impaired among patients on left ventricular assist device for 6 months Ann Thorac Surg 85 2008 1656 1661
180. S. Shoham, and L.W. Miller Cardiac assist device infections Curr Infect Dis Rep 11 2009 268 273
181. A.G. Gristina, J.J. Dobbins, B. Giammara, J.C. Lewis, and W.C. DeVries Biomaterial-centered sepsis and the total artificial heart. Microbial adhesion vs tissue integration JAM 259 1988 870 874
182. R.F. Padera Infection in ventricular assist devices: the role of biofilm Cardiovasc Pathol 15 2006 264 270
183. S.M. Gordon, S.K. Schmitt, and M. Jacobs Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Ann Thorac Surg 72 2001 725 730
184. H.A. Hanna, I.I. Raad, and B. Hackett Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients Chest 124 2003 1030 1038
185. L.A. Mermel, M. Allon, and E. Bouza Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America Clin Infect Dis 49 2009 1 45
186. N.P. O'Grady, M. Alexander, and E.P. Dellinger Guidelines for the prevention of intravascular catheter-related infections Infect Control Hosp Epidemiol 23 2002 759 769
187. A.J. Mangram, T.C. Horan, M.L. Pearson, L.C. Silver, and W.R. Jarvis Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee Infect Control Hosp Epidemiol 20 1999 250 278
188. W.L. Holman, B.K. Rayburn, and D.C. McGiffin Infection in ventricular assist devices: prevention and treatment Ann Thorac Surg 75 2003 S48 S57
189. R.O. Darouiche, M.J. Wall Jr, and K.M. Itani Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis N Engl J Med 362 2010 18 26
190. F.H. Edwards, R.M. Engelman, P. Houck, D.M. Shahian, and C.R. Bridges The Society of Thoracic Surgeons Practice Guideline Series: antibiotic prophylaxis in cardiac surgery, part I: duration Ann Thorac Surg 81 2006 397 404
191. S. Harbarth, M.H. Samore, D. Lichtenberg, and Y. Carmeli Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance Circulation 101 2000 2916 2921
192. R.F. Eyler, S.O. Butler, and P.C. Walker Vancomycin use during left ventricular assist device support Infect Control Hosp Epidemiol 30 2009 484 486
193. R. Engelman, D. Shahian, and R. Shemin The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part II: antibiotic choice Ann Thorac Surg 83 2007 1569 1576
194. T.M. Perl Prevention of Staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis Surgery 134 2003 S10 S17
195. E.A. Rose, A.C. Gelijns, and A.J. Moskowitz Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
196. W.L. Holman, S.J. Park, and J.W. Long Infection in permanent circulatory support: experience from the REMATCH trial J Heart Lung Transplant 23 2004 1359 1365
197. W. Wilson, K.A. Taubert, and M. Gewitz Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation 116 2007 1736 1754
198. T.J. Myers, T. Khan, and O.H. Frazier Infectious complications associated with ventricular assist systems ASAIO J 46 2000 S28 S36
199. M.K. Pasque, T. Hanselman, and K. Shelton Surgical management of Novacor drive-line exit site infections Ann Thorac Surg 74 2002 1267 1268
200. A. Zierer, S.J. Melby, and R.K. Voeller Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support Ann Thorac Surg 84 2007 515 520
201. R. Chinn, W. Dembitsky, and L. Eaton Multicenter experience: prevention and management of left ventricular assist device infections ASAIO J 51 2005 461 470
202. A. Garatti, B. Giuseppe, C.F. Russo, O. Marco, and V. Ettore Drive-line exit-site infection in a patient with axial-flow pump support: successful management using vacuum-assisted therapy J Heart Lung Transplant 26 2007 956 959
203. M. Hravnak, E. George, and R.L. Kormos Management of chronic left ventricular assist device percutaneous lead insertion sites J Heart Lung Transplant 12 1993 856 863
204. S.V. Baudouin, and T.W. Evans Nutritional support in critical care Clin Chest Med 24 2003 633 644
205. C. Scurlock, J. Raikhelkar, and J.I. Mechanick Impact of new technologies on metabolic care in the intensive care unit Curr Opin Clin Nutr Metab Care 12 2009 196 200
206. C. Scurlock, J. Raikhelkar, and J.I. Mechanick Intensive metabolic support: evolution and revolution Endocr Pract 14 2008 1047 1054
207. I. Khalid, P. Doshi, and B. DiGiovine Early enteral nutrition and outcomes of critically ill patients treated with vasopressors and mechanical ventilation Am J Crit Care 19 2010 261 268
208. S. Aslam, M. Hernandez, J. Thornby, B. Zeluff, and R.O. Darouiche Risk factors and outcomes of fungal ventricular-assist device infections Clin Infect Dis 50 2010 664 671
209. E. Bond, B. Bolton, and K. Nelson Nursing education and implications for left ventricular assist device destination therapy Prog Cardiovasc Nurs 19 2004 95 101
210. M.A. Stahl, and N.M. Richards Ventricular assist devices: developing and maintaining a training and competency program J Cardiovasc Nurs 16 2002 34 43
211. T.B. Millhaem, and K. Timm Identifying the educational needs of nursing staff: the role of the clinical nurse specialist in perinatal nursing J Nurses Staff Dev 23 2007 277 282
212. L. Savage, J. Murphey, and K. Joyce Developing and maintaining competency with circulatory assist devices: how to meet the challenge Prog Transplant 20 2010 125 128
213. S. Andrus, J. Dubois, C. Jansen, V. Kuttner, N. Lansberry, and L. Lukowski Teaching documentation tool: building a successful discharge Crit Care Nurse 23 2003 39 48
214. E.C. Holmes Outpatient management of long-term assist devices Cardiol Clin 21 2003 93 99
215. M.A. Murray, S. Osaki, and N.M. Edwards Multidisciplinary approach decreases length of stay and reduces cost for ventricular assist device therapy Interact Cardiovasc Thorac Surg 8 2009 84 88
216. M. Stahovich, S. Chillcott, and W.P. Dembitsky The next treatment option: using ventricular assist devices for heart failure Crit Care Nurs Q 30 2007 337 346
217. D.A. Moroney, and K. Powers Outpatient use of left ventricular assist devices: nursing, technical, and educational considerations Am J Crit Care 6 1997 355 362
218. M.S. Slaughter, M.A. Sobieski, M. Martin, M. Dia, and M.A. Silver Home discharge experience with the Thoratec TLC-II portable driver ASAIO J 53 2007 132 135
219. M.A. Dew, R.L. Kormos, and S. Winowich Quality of life outcomes in left ventricular assist system inpatients and outpatients ASAIO J 45 1999 218 225
220. K.L. Grady, P. Meyer, and A. Mattea Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation J Heart Lung Transplant 20 2001 657 669
221. K.L. Grady, P. Meyer, and A. Mattea Predictors of quality of life at 1 month after implantation of a left ventricular assist device Am J Crit Care 11 2002 345 352
222. National Association of Social Workers. Standards for Social Work Practice in Health Care Settings http://www.naswdc.org/practice/standards/ naswhealthcarestandards.pdf. 2012.
223. J. Adams, M. Kuchibhatla, and E.J. Christopher Association of depression and survival in patients with chronic heart failure over 12 years Psychosomatics 53 2012 339 346
224. W. Jiang, C. O'Connor, and S.G. Silva Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure Am Heart J 156 2008 437 444
225. C.M. O'Connor, W. Jiang, and M. Kuchibhatla Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial J Am Coll Cardiol 56 2010 692 699
226. A. McGrady, R. McGinnis, D. Badenhop, M. Bentle, and M. Rajput Effects of depression and anxiety on adherence to cardiac rehabilitation J Cardiopulm Rehabil Prev 29 2009 358 364
227. R. Humphrey Exercise physiology in patients with left ventricular assist devices J Cardiopulm Rehabil 17 1997 73 75
228. S.J. Goodlin, P.J. Hauptman, and R. Arnold Consensus statement: palliative and supportive care in advanced heart failure J Card Fail 10 2004 200 209
229. K.A. Bramstedt, and N.S. Wenger When withdrawal of life-sustaining care does more than allow death to take its course: the dilemma of left ventricular assist devices J Heart Lung Transplant 20 2001 544 548
230. K.A. Bramstedt, and P.J. Nash When death is the outcome of informed refusal: dilemma of rejecting ventricular assist device therapy J Heart Lung Transplant 24 2005 229 230
231. D.L. Wiegand, and P.G. Kalowes Withdrawal of cardiac medications and devices AACN Adv Crit Care 18 2007 415 425
232. K.L. Grady, P.M. Meyer, and A. Mattea Change in quality of life from before to after discharge following left ventricular assist device implantation J Heart Lung Transplant 22 2003 322 333
233. S.R. Wilson, M.M. Givertz, G.C. Stewart, and G.H. Mudge Jr Ventricular assist devices: the challenges of outpatient management J Am Coll Cardiol 54 2009 1647 1659
234. E.A. Genovese, M.A. Dew, and J.J. Teuteberg Early adverse events as predictors of 1-year mortality during mechanical circulatory support J Heart Lung Transplant 29 2010 981 988
235. M.R. Mehra, P.A. Uber, W.E. Uber, R.L. Scott, and M.H. Park Allosensitization in heart transplantation: implications and management strategies Curr Opin Cardiol 18 2003 153 158
236. A.L. Meyer, D. Malehsa, and C. Bara Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device Circ Heart Fail 3 2010 675 681
237. J. Klovaite, F. Gustafsson, S.A. Mortensen, K. Sander, and L.B. Nielsen Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II) J Am Coll Cardiol 53 2009 2162 2167
238. S. Crow, R. John, and A. Boyle Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices J Thorac Cardiovasc Surg 137 2009 208 215
239. S. Crow, D. Chen, and C. Milano Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients Ann Thorac Surg 90 2010 1263 1269
240. Z.T. Demirozu, R. Radovancevic, and L.F. Hochman Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device J Heart Lung Transplant 30 2011 849 853
241. E.A. Genovese, M.A. Dew, and J.J. Teuteberg Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation Ann Thorac Surg 88 2009 1162 1170
242. I. Nakajima, T.S. Kato, and K. Komamura Pre- and post-operative risk factors associated with cerebrovascular accidents in patients supported by left ventricular assist device. -Single center's experience in Japan- Circ J 75 2011 1138 1146
243. H. Tsukui, A. Abla, and J.J. Teuteberg Cerebrovascular accidents in patients with a ventricular assist device J Thorac Cardiovasc Surg 134 2007 114 123
244. R. Motallebzadeh, J.M. Bland, H.S. Markus, J.C. Kaski, and M. Jahangiri Neurocognitive function and cerebral emboli: randomized study of on-pump versus off-pump coronary artery bypass surgery Ann Thorac Surg 83 2007 475 482
245. D. van Dijk, A.M. Keizer, J.C. Diephuis, C. Durand, L.J. Vos, and R. Hijman Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review J Thorac Cardiovasc Surg 120 2000 632 639
246. R.J. Petrucci, J.G. Rogers, and L. Blue Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support J Heart Lung Transplant 31 2012 27 36
247. M.M. Hannan, S. Husain, and F. Mattner Working formulation for the standardization of definitions of infections in patients using ventricular assist devices J Heart Lung Transplant 30 2011 375 384
248. M. Bedi, R. Kormos, S. Winowich, D.M. McNamara, M.A. Mathier, and S. Murali Ventricular arrhythmias during left ventricular assist device support Am J Cardiol 99 2007 1151 1153
249. D.A. Cesario, L.A. Saxon, M.K. Cao, M. Bowdish, and M. Cunningham Ventricular tachycardia in the era of ventricular assist devices J Cardiovasc Electrophysiol 22 2011 359 363
250. M. Refaat, E. Chemaly, D. Lebeche, J.K. Gwathmey, and R.J. Hajjar Ventricular arrhythmias after left ventricular assist device implantation Pacing Clin Electrophysiol 31 2008 1246 1252
251. O. Ziv, J. Dizon, A. Thosani, Y. Naka, A.R. Magnano, and H. Garan Effects of left ventricular assist device therapy on ventricular arrhythmias J Am Coll Cardiol 45 2005 1428 1434
252. M. Andersen, R. Videbaek, S. Boesgaard, K. Sander, P.B. Hansen, and F. Gustafsson Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II) J Heart Lung Transplant 28 2009 733 735
253. J. Martin, O. Friesewinkel, C. Benk, S. Sorg, S. Schultz, and F. Beyersdorf Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year J Heart Lung Transplant 25 2006 384 390
254. R.C. Starling, Y. Naka, and A.J. Boyle Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) J Am Coll Cardiol 57 2011 1890 1898
255. R. John, F. Kamdar, and P. Eckman Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices Ann Thorac Surg 92 2011 1593 1599
256. M. Cadeiras, H. Nagaraj, J.K. Kirklin, W.L. Holman, S.V. Pamboukian, and V.K. Misra Use of a vascular plug to percutaneously occlude the outflow conduit of a dysfunctional left ventricular assist device J Heart Lung Transplant 30 2011 733 734
257. G.S. Chrysant, D.A. Horstmanshof, and T. Snyder Successful percutaneous management of acute left ventricular assist device stoppage ASAIO J 56 2010 483 485
258. A.E. Eckhauser, W.V. Melvin, and K.W. Sharp Management of general surgical problems in patients with left ventricular assist devices Am Surg 72 2006 158 161
259. A. Garatti, G. Bruschi, and T. Colombo Noncardiac surgical procedures in patient supported with long-term implantable left ventricular assist device Am J Surg 197 2009 710 714
260. C. Schmid, M. Wilhelm, K.H. Dietl, C. Schmidt, D. Hammel, and H.H. Scheld Noncardiac surgery in patients with left ventricular assist devices Surgery 129 2001 440 444
261. J. Stehlik, D.M. Nelson, and A.G. Kfoury Outcome of noncardiac surgery in patients with ventricular assist devices Am J Cardiol 103 2009 709 712
262. T.V. Votapka, D.G. Pennington, L.R. McBride, D.L. Kaminski, C.H. Andrus, and M.T. Swartz Noncardiac operations in patients supported with mechanical circulatory support devices J Am Coll Surg 179 1994 318 320
263. D.J. Goldstein, S.L. Mullis, and E.S. Delphin Noncardiac surgery in long-term implantable left ventricular assist-device recipients Ann Surg 222 1995 203 207
264. M.E. Stone, W. Soong, M. Krol, and D.L. Reich The anesthetic considerations in patients with ventricular assist devices presenting for noncardiac surgery: a review of eight cases Anesth Analg 95 2002 42 49
265. P.J. Chestovich, M.H. Kwon, H.G. Cryer, A. Tillou, and J.R. Hiatt Surgical procedures for patients receiving mechanical cardiac support Am Surg 77 2011 1314 1317
266. M.M. Mountis, and R.C. Starling Management of left ventricular assist devices after surgery: bridge, destination, and recovery Curr Opin Cardiol 24 2009 252 256
267. Thoratec Corporation Heart Mate II community living manual: your guide to successful LVAS patient discharges 2011 Thoracec Corp Pleasanton, CA
268. T.J. Van de Bussche, L.G. Edwards, T. Elliott, S. Harton, D. Rivard, and A.C. Wolfe Jr Regionalized approach to emergency medical services training for the care of patients with mechanical assist devices Prog Transplant 20 2010 129 132
269. Disease specific care certification workbook. Oakbrook Terrace, IL: Joint Commission Resources, Inc., 2012.
270. S.V. Pamboukian, J.A. Tallaj, and R.N. Brown Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol J Heart Lung Transplant 30 2011 879 887
271. M.A. Simon, B.A. Primack, and J. Teuteberg Left ventricular remodeling and myocardial recovery on mechanical circulatory support J Card Fail 16 2010 99 105
272. M. Dandel, Y. Weng, and H. Siniawski Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy Circulation 118 2008 S94 105
273. R. Hetzer, J.H. Muller, Y. Weng, R. Meyer, and M. Dandel Bridging-to-recovery Ann Thorac Surg 71 2001 S109 S113
274. D.M. Mancini, A. Beniaminovitz, and H. Levin Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure Circulation 98 1998 2383 2389
275. T. Khan, R.M. Delgado, and B. Radovancevic Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation J Heart Lung Transplant 22 2003 137 146
276. J.N. Kirkpatrick, S.E. Wiegers, and R.M. Lang Left ventricular assist devices and other devices for end-stage heart failure: utility of echocardiography Curr Cardiol Rep 12 2010 257 264
277. E. Catena, F. Milazzo, and E. Montorsi Left ventricular support by axial flow pump: the echocardiographic approach to device malfunction J Am Soc Echocardiogr 18 2005 1422
278. G.M. Scalia, P.M. McCarthy, R.M. Savage, N.G. Smedira, and J.D. Thomas Clinical utility of echocardiography in the management of implantable ventricular assist devices J Am Soc Echocardiogr 13 2000 754 763
279. L.M. Baddour, M.A. Bettmann, and A.F. Bolger Nonvalvular cardiovascular device-related infections Circulation 108 2003 2015 2031
280. S.W. Pak, N. Uriel, and H. Takayama Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices J Heart Lung Transplant 29 2010 1172 1176
281. J. Cowger, F.D. Pagani, J.W. Haft, M.A. Romano, K.D. Aaronson, and T.J. Kolias The development of aortic insufficiency in left ventricular assist device-supported patients Circ Heart Fail 3 2010 668 674
282. J.H. Connelly, J. Abrams, T. Klima, W.K. Vaughn, and O.H. Frazier Acquired commissural fusion of aortic valves in patients with left ventricular assist devices J Heart Lung Transplant 22 2003 1291 1295
283. C.M. Carr, J. Jacob, S.J. Park, B.L. Karon, E.E. Williamson, and P.A. Araoz CT of left ventricular assist devices Radiographics 30 2010 429 444
284. S.V. Raman, A. Sahu, A.Z. Merchant, L.B. Louis, M.S. Firstenberg, and B. Sun Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management J Heart Lung Transplant 29 2010 79 85
285. D. Acharya, S. Singh, and J.A. Tallaj Use of gated cardiac computed tomography angiography in the assessment of left ventricular assist device dysfunction ASAIO J 57 2011 32 37
286. D. Mancini, T. LeJemtel, and K. Aaronson Peak VO (2): a simple yet enduring standard Circulation 101 2000 1080 1082
287. J.N. de, H. Kirkels, and J.R. Lahpor Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting? J Am Coll Cardiol 37 2001 1794 1799
288. J. Haft, W. Armstrong, and D.B. Dyke Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices Circulation 116 2007 I8 15
289. B.E. Jaski, R.J. Lingle, and J. Kim Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial J Heart Lung Transplant 18 1999 1031 1040
290. J.C. Matthews, F.D. Pagani, S. Wright, M. Daly-Myers, and D.B. Dyke Maximal oxygen uptake improvements with long term LVAD support [abstract] J Heart Lung Transplant 24 2005 S107
291. S. Maybaum, D. Mancini, and S. Xydas Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group Circulation 115 2007 2497 2505
292. C. Pulz, R.V. Diniz, and A.N. Alves Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure Can J Cardiol 24 2008 131 135
293. F.J. Morales, A. Martinez, and M. Mendez A shuttle walk test for assessment of functional capacity in chronic heart failure Am Heart J 138 1999 291 298
294. B. Pollentier, S.L. Irons, and C.M. Benedetto Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review Cardiopulm Phys Ther J 21 2010 13 21
295. B. Spilker Quality of life and pharmacoeconomics in clinical trials 2nd ed. 1996 Lippincott Williams & Williams New York
296. G.T. O'Connor, J.E. Buring, and S. Yusuf An overview of randomized trials of rehabilitation with exercise after myocardial infarction Circulation 80 1989 234 244
297. N.B. Oldridge, G.H. Guyatt, M.E. Fischer, and A.A. Rimm Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials JAMA 260 1988 945 950
298. R. Humphrey, and M.N. Bartels Exercise, cardiovascular disease, and chronic heart failure Arch Phys Med Rehabil 82 2001 S76 S81
299. C.M. O'Connor, D.J. Whellan, and K.L. Lee Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial JAMA 301 2009 1439 1450
300. B.E. Jaski, J. Kim, and R.S. Maly Effects of exercise during long-term support with a left ventricular assist device. Results of the experience with left ventricular assist device with exercise (EVADE) pilot trial Circulation 95 1997 2401 2406
301. M. Nishimura, B. Radovancevic, P. Odegaard, T. Myers, W. Springer, and O.H. Frazier Exercise capacity recovers slowly but fully in patients with a left ventricular assist device ASAIO J 42 1996 M568 M570
302. S. Salzberg, M. Lachat, and G. Zund Left ventricular assist device as bridge to heart transplantation - lessons learned with the MicroMed DeBakey axial blood flow pump Eur J Cardiothorac Surg 24 2003 113 118
303. T.M. Morrone, L.A. Buck, and K.A. Catanese Early progressive mobilization of patients with left ventricular assist devices is safe and optimizes recovery before heart transplantation J Heart Lung Transplant 15 1996 423 429
304. C.S. Perme, R.E. Southard, D.L. Joyce, G.P. Noon, and M. Loebe Early mobilization of LVAD recipients who require prolonged mechanical ventilation Tex Heart Inst J 33 2006 130 133
305. B. Mettauer, B. Geny, and E. Lonsdorfer-Wolf Exercise training with a heart device: a hemodynamic, metabolic, and hormonal study Med Sci Sports Exerc 33 2001 2 8
306. A. Ueno, and Y. Tomizawa Cardiac rehabilitation and artificial heart devices J Artif Organs 12 2009 90 97
307. A.S. Leon, B.A. Franklin, and F. Costa Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation Circulation 111 2005 369 376
308. Cardiac rehabilitation programs A statement for healthcare professionals from the American Heart Association Circulation 90 1994 1602 1610
309. W.L. Holman, W.E. Pae, and J.J. Teutenberg INTERMACS: interval analysis of registry data J Am Coll Surg 208 2009 755 761
310. A.Y. Gasparyan, T. Watson, and G.Y. Lip The role of aspirin in cardiovascular prevention: implications of aspirin resistance J Am Coll Cardiol 51 2008 1829 1843
311. P.J. Mason, A.K. Jacobs, and J.E. Freedman Aspirin resistance and atherothrombotic disease J Am Coll Cardiol 46 2005 986 993
312. R. Houel, E. Mazoyer, and B. Boval Platelet activation and aggregation profile in prolonged external ventricular support J Thorac Cardiovasc Surg 128 2004 197 202
313. O. Dewald, C. Schmitz, and H. Diem Platelet activation markers in patients with heart assist device Artif Organs 29 2005 292 299
314. R. Radovancevic, N. Matijevic, and A.W. Bracey Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices ASAIO J 55 2009 459 464
315. B. Steinlechner, M. Dworschak, and B. Birkenberg Platelet dysfunction in outpatients with left ventricular assist devices Ann Thorac Surg 87 2009 131 137
316. U. Geisen, C. Heilmann, and F. Beyersdorf Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease Eur J Cardiothorac Surg 33 2008 679 684
317. T.E. Warkentin, J.C. Moore, and D.G. Morgan Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 340 1992 35 37
318. T.E. Warkentin, J.C. Moore, S.S. Anand, E.M. Lonn, and D.G. Morgan Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome Transfus Med Rev 17 2003 272 286
319. Letsou GV, Shah N, Gregoric ID, Myers TJ, Delgado R, Frazier OH. Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. J Heart Lung Transplant 2005;24:105-9.
320. A. Veyradier, A. Balian, and M. Wolf Abnormal von Willebrand factor in bleeding angiodysplasias of the digestive tract Gastroenterology 120 2001 346 353
321. E.J. Birks, P.D. Tansley, and J. Hardy Left ventricular assist device and drug therapy for the reversal of heart failure N Engl J Med 355 2006 1873 1884
322. E.J. Birks, R.S. George, and M. Hedger Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study Circulation 123 2011 381 390
323. F. Kamdar, A. Boyle, K. Liao, M. Colvin-Adams, L. Joyce, and R. John Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients J Heart Lung Transplant 28 2009 352 359
324. M.D. Thomas, C. Wood, M. Lovett, L. Dembo, and G. O'Driscoll Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban J Heart Lung Transplant 27 2008 925 927
325. M.S. Kiernan, D.T. Pham, D. DeNofrio, and N.K. Kapur Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics J Thorac Cardiovasc Surg 142 2011 712 714
326. R. Delgado 3rd, O.H. Frazier, and T.J. Myers Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device J Heart Lung Transplant 24 2005 231 233
327. M. Rothenburger, M.J. Wilhelm, and D. Hammel Treatment of thrombus formation associated with the MicroMed DeBakey VAD using recombinant tissue plasminogen activator Circulation 106 2002 I189 I192
328. K. Lockard, L. DeGore, and P. Schwarm Lack of improvement in prealbumin at two weeks predicts a poor outcome after mechanical circulatory support [abstract] J Heart Lung Transplant 28 2009 S66
329. J. Butler, R. Howser, P.M. Portner, and R.N. Pierson 3rd Body mass index and outcomes after left ventricular assist device placement Ann Thorac Surg 79 2005 66 73
330. M.M. Refaat, T. Tanaka, and R.L. Kormos Survival benefit of implantable cardioverter-defibrillators in left ventricular assist device-supported heart failure patients J Card Fail 18 2012 140 145
331. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace 8 2006 651 745
332. V. Fuster, L.E. Ryden, and D.S. Cannom ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society J Am Coll Cardiol 57 2011 e101 e198
333. D.P. Zipes, A.J. Camm, and M. Borggrefe ACC/AHA/ESC 2006 Guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e385 e484
334. T. Jaarsma, J.M. Beattie, and M. Ryder Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology Eur J Heart Fail 11 2009 433 443
335. J.L. Levenson, and M.E. Olbrisch Psychiatric aspects of heart transplantation Psychosomatics 34 1993 114 123
336. R. Petrucci, D. Kushon, R. Inkles, J. Fitzpatrick, C. Twomey, and L. Samuels Cardiac ventricular support. Considerations for psychiatry Psychosomatics 40 1999 298 303
337. B. Bunzel, and G. Wollenek Heart transplantation: are there psychosocial predictors for clinical success of surgery? Thorac Cardiovasc Surg 42 1994 103 107
338. C. Kugler, D. Malehsa, and U. Tegtbur Health-related quality of life and exercise tolerance in recipients of heart transplants and left ventricular assist devices: a prospective, comparative study J Heart Lung Transplant 30 2011 204 210
339. D.S. Kucukaksu, E. Sener, A. Undar, G.P. Noon, and O. Tasdemir First Turkish experience with the MicroMed DeBakey VAD Tex Heart Inst J 30 2003 114 120
340. K. Laederach-Hofmann, and B. Bunzel Noncompliance in organ transplant recipients: a literature review Gen Hosp Psychiatry 22 2000 412 424
341. B. Bunzel, and K. Laederach-Hofmann Solid organ transplantation: are there predictors for posttransplant noncompliance? A literature overview Transplantation 70 2000 711 716
342. A. Baba, G. Hirata, and F. Yokoyama Psychiatric problems of heart transplant candidates with left ventricular assist devices J Artif Organs 9 2006 203 208
343. K. Tigges-Limmer, M. Schonbrodt, D. Roefe, L. Arusoglu, M. Morshuis, and J.F. Gummert Suicide after ventricular assist device implantation J Heart Lung Transplant 29 2010 692 694
344. M.A. Dew, R.L. Kormos, and S. Winowich Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices J Heart Lung Transplant 20 2001 1199-1212
345. R.J. Petrucci, S. Wright, and Y. Naka Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices J Heart Lung Transplant 28 2009 542 549
346. P. Marcus Left ventricular assist devices: psychosocial challenges in the elderly Ann Thorac Surg 88 2009 e48 e49
347. D.M. Dudzinski Ethics guidelines for destination therapy Ann Thorac Surg 81 2006 1185 1188
348. M.E. Olbrisch, and J.L. Levenson Psychosocial evaluation of heart transplant candidates: an international survey of process, criteria, and outcomes J Heart Lung Transplant 10 1991 948 955
349. J.S. Temel, J.A. Greer, and A. Muzikansky Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med 363 2010 733 742
350. K.M. Swetz, M.R. Freeman, and O.F. AbouEzzeddine Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy Mayo Clin Proc 86 2011 493 500